Magnetic Targeted Pemetrexed-Loaded Albumin Nanoparticles and Their Efficacy in Lung Cancer
DOI:
https://doi.org/10.58600/eurjther2814Keywords:
albumin nanoparticle, cell culture, controlled drug release, magnetic targeting, pemetrexedAbstract
Objective: Albumin, a biodegradable, biocompatible, and non-toxic plasma protein, is widely used as a nanocarrier in drug delivery systems. Pemetrexed, a potent thymidylate synthase inhibitor for non-small cell lung cancer (NSCLC), is limited by severe systemic side effects. Embedding magnetite within albumin carriers enables external-field guidance (magnetic targeting), which enhances tumor accumulation while reducing off-target exposure. Additionally, employing genipin as a natural, biodegradable, and low-cytotoxicity crosslinker stabilizes the albumin matrix while eliminating the use of toxic aldehyde-based agents.
This study introduces a genipin-crosslinked, magnetically targetable albumin nanoparticle platform for enhanced and controlled delivery of pemetrexed to lung cancer cells. Unlike previous pemetrexed–albumin systems, this dual design—combining genipin crosslinking with magnetite-mediated targeting—offers improved structural stability, biocompatibility, and site-specific delivery potential
Methods: Bovine serum albumin (BSA) nanoparticles were prepared via desolvation using genipin as the crosslinker and magnetite for magnetic responsiveness. Key formulation parameters—BSA concentration, genipin content, magnetite ratio, reaction time, and drug loading—were systematically optimized. Drug release from free pemetrexed and nanoparticle formulations was evaluated at pH 7.4 and 5.5. Nanoparticles were characterized by SEM, FTIR, and zeta potential; cytotoxic efficacy was assessed in A549-luc-C8 and CRL-5807 lung cancer cells.
Results: The nanoparticle yielded spherical, negatively charged nanoparticles with sustained, pH-responsive release. In vitro, the genipin-crosslinked, magnetite-containing nanoparticles demonstrated improved antitumor efficacy versus free drug.
Conclusion: Magnetite provides a handle for external magnetic guidance, supporting targeted delivery, while genipin crosslinking minimizes residual crosslinker toxicity and stabilizes the carrier network. Together, genipin crosslinking + magnetic targeting define the novelty and translational potential of this system, with the prospect of reducing systemic exposure via controlled, site-directed delivery.
References
Cattamanchi A. (2018) What to know about lung cancer. Medical News Today. Retrieved April 29, 2019, from https://www.medicalnewstoday.com/articles/323701.php
Ak G, Yilmaz H, Gunes A, Hamarat Sanlier S. (2018) In vitro and in vivo evaluation of folate receptor-targeted novel magnetic drug delivery system for ovarian cancer therapy. Artif Cells Nanomed Biotechnol. 46(Suppl 1):926–937. https://doi.org/10.1080/21691401.2018.1439838
Cancer Treatment Centers of America. (2019) About lung cancer. Retrieved April 29, 2019, from https://www.cancercenter.com/cancer-types/lung-cancer/about
National Cancer Institute. (2021) Targeted therapy. Retrieved April 28, 2019, from https://www.cancer.gov/about-cancer/treatment/types/targeted-therapies
Türker A, Dizdar Ö. (2017) Chemotherapeutics. Meslek içi sürekli eğitim dergisi. Ministry of National Education, Health Services.
Adjei AA. (2004) Pharmacology and mechanism of action of pemetrexed. Clin Lung Cancer. 5(Suppl 2):S51–S55. https://doi.org/10.3816/clc.2004.s.003
Butler M, Ng YF, Pudney PDA. (2003) Mechanism and kinetics of the crosslinking reaction between biopolymers containing primary amine groups and genipin. J Polym Sci A Polym Chem. 41(24):3941–3953. https://doi.org/10.1002/pola.10960
Langer K, Balthasar S, Vogel V, Dinauer N, von Briesen H, Schubert D. (2003) Optimization of the preparation process for human serum albumin (HSA) nanoparticles. Int J Pharm. 257(1–2):169–180. https://doi.org/10.1016/S0378-5173(03)00134-0
Sofias AM, Dunne M, Storm G, Allen C. (2017). The battle of "nano" paclitaxel. Adv Drug Deliv Rev. 1;122:20-30. https://doi.org/10.1016/j.addr.2017.02.003
Hamarat Şanlıer Ş, Ak G, Yılmaz H, Ünal A, Bozkaya ÜF, Tanıyan G, et al. (2019) Development of ultrasound-triggered and magnetic-targeted nanobubble system for dual-drug delivery. J Pharm Sci. 108(4):1272–1283. https://doi.org/10.1016/j.xphs.2018.10.030
Zhao H, Saatchi K, Hafeli UO. (2009) Preparation of biodegradable magnetic microspheres with poly(lactic acid)-coated magnetite. J Magn Magn Mater. 321(10):1356–1363. https://doi.org/10.1016/j.jmmm.2009.02.038
Sleep D. (2015) Albumin and its application in drug delivery. Expert Opin Drug Deliv. 12(5):793–812. https://doi.org/10.1517/17425247.2015.993313
Zhang Y, Mao L, Liu J, Liu T. (2017) Self-fluorescent drug delivery vector based on genipin-crosslinked polyethylenimine conjugated globin nanoparticle. Mater Sci Eng C. 71:17–24. https://doi.org/10.1016/j.msec.2016.09.059
Ak G, Yilmaz H, Hamarat Sanlier S. (2014) Preparation of magnetically responsive albumin nanospheres and in vitro drug release studies. Artif Cells Nanomed Biotechnol. 42(1):18-26. https://doi.org/10.3109/21691401.2013.768627
Shahgholian N, Rajabzadeh G, Malaekeh-Nikouei B. (2017) Preparation and evaluation of BSA-based hydrosol nanoparticles cross-linked with genipin for oral administration of poorly water-soluble curcumin. Int J Biol Macromol. 105:751–759. https://doi.org/10.1016/j.ijbiomac.2017.06.083
Ak G, Aksu D, Çapkın E, Sarı Ö, Kımız Geboloğlu İ, Hamarat Şanlıer Ş. (2019) Delivery of pemetrexed by magnetic nanoparticles: Design, characterization, in vitro and in vivo assessment. Prep Biochem Biotechnol. 49(5):460–471. https://doi.org/10.1080/10826068.2019.1692220
Langer K, Balthasar S, Vogel V, Dinauer N, von Briesen H, Schubert D. (2003) Optimization of the preparation process for human serum albumin (HSA) nanoparticles. Int J Pharm. 257(1–2):169–180. https://doi.org/10.1016/S0378-5173(03)00134-0
Li FQ, Su H, Wang J, Liu JY, Zhu QG, Fei YB, et al. (2008) Preparation and characterization of sodium ferulate entrapped bovine serum albumin nanoparticles for liver targeting. Int J Pharm. 349(1–2):274–282. https://doi.org/10.1016/j.ijpharm.2007.08.001
Xie L, Tong W, Yu D, Xu J, Li J, Gao C. (2012) Bovine serum albumin nanoparticles modified with multilayers and aptamers for pH-responsive and targeted anti-cancer drug delivery. J Mater Chem. 22(12):6053. https://doi.org/10.1039/c2jm16831f
Zeybek A, Şanlı-Mohamed G, Ak G, Yılmaz H, Şanlıer Ş. (2014) In vitro evaluation of doxorubicin-incorporated magnetic albumin nanospheres. Chem Biol Drug Des. 84(1):108–115. https://doi.org/10.1111/cbdd.12300
Bradford MM. (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein–dye binding. Anal Biochem. 72(1–2):248–254. https://doi.org/10.1016/0003-2697(76)90527-3
Manickam B, Sreedharan R, Elumalai M. (2014) Genipin – The natural water soluble cross-linking agent and its importance in the modified drug delivery systems: An overview. Curr Drug Deliv. 11(2):139–145. https://doi.org/10.2174/15672018113106660059
Demir D. (2013) Formulation and in vitro evaluation of docetaxel loaded nanoparticles. Master’s thesis, Hacettepe University.
Tüylek Z. (2017) İlaç Taşıyıcı Sistemler Ve Nanoteknolojik Etkileşim. Bozok Tıp Dergisi. 7(3):89–98.
Çelik M. (2014) Drug targeting techniques in pharmaceutical biotechnology. Bachelor’s thesis, Erciyes University.
Downloads
Published
How to Cite
License
Copyright (c) 2025 Ayşe Ünal, Şenay Hamarat Şanlıer
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The content of this journal is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Funding data
-
Ege University Research Foundation
Grant numbers 17 FEN 005
